ClearanceFDA authorization
Permission to sell. Essential — and, on its own, commercially silent. No code, no coverage policy, and no payment rate come with it.
The podcast for device CEOs & founders · Launching December 2026
You built the device. You cleared the FDA. Then a hospital value committee asked the question no one prepared you for: “How do we get paid for this?”
Market Access Decoded answers that question — in plain English, decision-first — so coding, coverage, and payment stop being the reason a good device stalls.
Drops with the December launch, alongside Episodes 1–3. No episodes are live yet — join the list below and you’ll be first to hear it.
Why devices stall
Most founders plan for the FDA and stop there. Hospitals and physicians don’t adopt on clearance alone — they adopt when the economics work at their site of care. Every episode maps where you are on this path, and what unblocks the next step.
Permission to sell. Essential — and, on its own, commercially silent. No code, no coverage policy, and no payment rate come with it.
Can the hospital or physician even describe your procedure on a claim? If there’s no code — or the wrong code — there’s nothing to pay against.
Will payers say yes, for which patients, and with what evidence? A code without coverage is a denial waiting to happen.
Does the payment cover the hospital’s or practice’s cost of using your device? This is the number your champion has to defend in committee — and the one this show decodes every week.
“A great device with bad economics loses to a good device someone can get paid to use.”
Launch season · December 2026
All three drop together at launch. Each one starts with the CEO problem, explains the mechanism in plain English, and closes with a short checklist you can act on Monday morning.
The CEO question: “CMS just changed the rates — what does that do to my forecast?”
The CEO question: “The hospital loves it clinically and still won’t buy — why?”
The CEO question: “Why did the CPT panel say ‘not widespread enough’?”
How every episode works
No jargon for its own sake. If a term matters to a buying decision, we define it in one sentence and move on to what you should do about it.
The stalled deal, the committee objection, the denial pattern — the moment this issue costs you revenue.
How coding, coverage, or payment actually decides it — CMS, the AMA, and payers, translated into plain English.
Three to five concrete moves: what to ask your team, your KOLs, or your reimbursement partner this week.
Who it’s for
Your host
David has spent 25 years getting medical devices coded, covered, and paid — most recently as Leader, U.S. Health Economics and Reimbursement at W. L. Gore, and now as founder of Market Access Experts in Anthem, Arizona. He started this show because the same payment surprise kept killing good devices at the same point in the sale.
“I’m not here to teach you to code a claim. I’m here so payment never blindsides your next sale again.”
Listen & follow
Market Access Decoded will be on Apple Podcasts, Spotify, and YouTube at launch, with all three episodes live together. Join the launch list and we’ll send you the trailer and Episode 1 the day they drop — no weekly spam, just the show.
Looking for the old name? This is the show formerly announced as Device Coder — same host, same December launch, new name built for the CEO in the room. devicecoder.com will redirect here once the new domain is live.
Be a guest
Device CEOs and founders who’ve lived a market-access fight come first. If that’s your story, write to info@marketaccessexperts.com.
Book a free 20-minute reimbursement call with David. Bring the deal that’s stalling — you’ll leave with where you sit on coding, coverage, and payment, and the next move.